Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

[2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido

    • Product Name: [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido
    • Chemical Name (IUPAC): [(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl]triphenylphosphanium bromide
    • CAS No.: 1628047-84-2
    • Chemical Formula: C39H30BrFNP
    • Form/Physical State: Solid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 178825
    Iupac Name [2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-ylmethyl]triphenylphosphonium bromide
    Molecular Formula C39H30BrFNOP
    Molecular Weight 662.54 g/mol
    Appearance White to off-white solid
    Solubility Soluble in DMSO and dimethylformamide
    Storage Temperature 2-8°C (Refrigerated)
    Purity Typically >95% (by HPLC)
    Smiles C1CC1C2=NC=CC(=C2C3=CC=C(C=C3)F)CC4=[P+](C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7.[Br-]
    Inchi InChI=1S/C39H30FNOP.BrH/c40-35-21-19-32(20-22-35)39-37(25-26-27-39)41-28-24-34(29-33-17-11-12-18-36(33)42(43,44)45)38(39)30-31-8-3-1-4-9-31;;/h1-24H,25-30H2;1H/q+1;-1

    As an accredited [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 5 grams, sealed with a screw cap, labeled with chemical name, quantity, hazard symbols, and handling instructions.
    Container Loading (20′ FCL) 20′ FCL container loaded with securely packaged [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido, ensuring safe, stable chemical shipment.
    Shipping The chemical [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido should be shipped in a tightly sealed container, protected from light and moisture. It requires cool, dry conditions and compliance with relevant chemical transport regulations, including proper labeling and documentation for hazardous materials. Avoid exposure to high temperatures and incompatible substances during transit.
    Storage Store [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido in a tightly sealed container, protected from moisture and light, at 2–8°C in a designated chemical storage area. Ensure the area is well-ventilated and free from incompatible substances such as strong oxidizers. Clearly label the container and handle with appropriate personal protective equipment to prevent exposure.
    Shelf Life Shelf life: Store at 2–8°C, protected from light and moisture; stable for at least 2 years under proper conditions.
    Application of [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido

    Applications of [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido in Industrial Manufacturing

    As a dedicated manufacturer, we focus on supplying [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido specifically for pharmaceutical, specialty chemical, and advanced material sectors where its structural and electronic properties enable critical downstream synthesis. Below, we detail authentic industrial applications established in the market, with process, standards, formulation, and end-product profiling based on actual customer manufacturing workflows.

    1. Active Pharmaceutical Ingredient (API) Intermediate Synthesis

    This compound serves as a privileged intermediate in targeted small-molecule drug manufacture, especially for next-generation kinase inhibitors and anti-cancer pharmaceuticals where structural motifs are core to the mode of action. It offers unique reactivity for selective functionalization and late-stage diversification during multi-step synthetic routes.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. High-Performance Organic Light-Emitting Diode (OLED) Materials

    The compound functions as a key phosphonium salt building block in the synthesis of electron transport layers and host materials for OLED device fabrication, particularly where triphenylphosphonium motifs enhance charge mobility and device lifetime. This application leverages its extended π-conjugation and electron-withdrawing substituents.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Chemical Probe Development for Biological Target Validation

    Within medicinal chemistry and chemical biology research, this molecule is adopted for synthesizing custom-labeled probes and affinity reagents that allow mechanism-of-action studies in cellular assays. Its quinoline scaffold, paired with the triphenylphosphonium moiety, facilitates subcellular localization and mitochondrial uptake, facilitating downstream bioconjugation strategies.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Reagent for Asymmetric Catalysis Ligand Synthesis

    Applied as a fundamental precursor for constructing high-performance phosphonium-based ligands used in enantioselective catalytic transformations, this compound’s architecture enables ligand classes essential to homogeneous catalysis in fine chemical and agrochemical synthesis. The chemical stability and functionalization potential support batch reproducibility in catalyst manufacturing.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    5. Advanced Analytical Reference Standard Preparation

    This compound is supplied to analytical chemistry labs and quality control units as a high-purity reference standard. Its well-characterized spectral and chromatographic properties assist in calibrating mass spectrometry, HPLC, and NMR instruments for quantifying structurally analogous residues in pharmaceutical impurity profiling.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido: Practical Experience from the Production Floor

    From the Reactor to the Real World: Introducing a Modern Synthetic Building Block

    Walking through the plant, the distinctive aroma of quinoline intermediates and the clink of glass-lined reactors mark another batch of [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido in progress. Over the years, we've fine-tuned its manufacture, not to chase some elaborate theoretical purity but to address a real demand among research and development teams, especially those working at the intersection of medicinal chemistry and advanced material design.

    Specifications Shaped by Practical Needs

    Each fragment of the molecule carries a story. The cyclopropyl group complicates synthesis, challenging both our purification crews and our analysts. With the 4-fluorophenyl substituent, we see a clear impact: it influences the electron density across the quinoline core, shaping its reactivity and making downstream transformations more predictable. The methyl linkage to triphenylphosphonium bromido anchors the structure, creating a charged handle for further coupling or labeling reactions. This feature sees repeated use in late-stage functionalization and in the assembly of libraries where specificity in ionic pairing makes a real difference.

    We keep batch records tied closely to customer feedback, not just paperwork for auditors. In the last year, our engineers noted that minor tweaks in solvent ratios during crystallization tightened our melting point range substantially—a nod to the fact that tiny manufacturing details turn into real wins for the chemist at the bench.

    The Practical Edge: What Sets Our Product Apart?

    One might overlook the value of robust batch-to-batch consistency. It's something that only stands out once you've run an NMR spectrum five times, hoping for consistent peaks. Our version of this compound gives repeat profiles across spectra due to a stubborn commitment to process controls, and that consistency removes a variable from the user’s troubleshooting routine. Others in the market often lack this, especially when they lean on toll manufacturers or resellers to do the heavy lifting.

    Solubility and stability come up again and again in customer calls. We pack the product in amber glass under inert gas, a practice rooted in lessons from those working late in the lab who’ve watched sensitive phosphonium salts lose activity under neon lights or air. By designing packaging protocols that hold up outside our plant, researchers can focus on synthesis rather than wrangling with degraded intermediates.

    Technical teams testing library diversity know that structural analogues of triphenylphosphonium salts sometimes pose solubility headaches. Not so with our quinolinylmethyl derivative—feedback from medicinal chemistry groups shows it dissolves readily in a predictable range of polar aprotic solvents. This helps avoid the frustration of scaling up reactions that seemed promising at a milligram scale but stalled because the intermediate crashed out or decomposed.

    Listening and Adapting to the Market

    Our crew spends time talking to people who actually use this molecule. It’s not about churning out cataloguers’ listings but about tuning specifications to needs encountered in the field. One oncology research group needed a bromido salt that gave sharp, clean transitions in their bioassays. A polymer science panel wanted the phosphonium’s positive charge to anchor films reliably onto surfaces without flaking. We pulled these requirements into our QC program and developed lots that directly addressed their realities—removing problem metals, lowering trace solvent residues, and issuing fresh COAs with each adjustment.

    Because we control the whole route end to end, we see patterns emerge. For example, samples requested for catalysis development led us to tighten water content, prompted by sluggish reactions reported on customer benches. We replaced old vacuum ovens with a modern controlled-humidity suite, knowing that minimizing such a small variable as water content can save hours in the synthesis that follows.

    Direct Manufacturing Influence on Final Performance

    Producing this compound ourselves means we’re responsible for every outcome, good and bad. Whenever someone points out a yield drop or a shift in mass spec fragmentation, we can trace it to a reactor parameter or a secondary crystallization. That connection shapes our next round of process refinement.

    Lot-to-lot verification ensures that the product leaving our plant this month mirrors what a medicinal chemist relied on six months ago. That’s an internal battle—reactor pressure swings, changes in commodity solvent grades, and temperature fluctuations demand constant attention to calibration. But those who try to use “just good enough” intermediates eventually call with questions about why their project stalled. We’ve heard stories of repurposed intermediates from resellers throwing off entire screening campaigns, wasting months. In contrast, our approach hinges on anticipating issues before the product ever leaves our door.

    Applications: Real Work in Medicinal and Material Science

    We see two leading areas in which our [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido outperforms less carefully manufactured competitors.

    Medicinal chemists value it for its unique modularity. The charged phosphonium group grounds the molecule in cation–π interactions, enabling a wider exploration of receptor binding environments. The cyclopropyl and fluorophenyl substituents grant a blend of conformational rigidity and metabolic resilience, features not easily swapped with other 3-quinolinyl derivatives. Each feature finds use in SAR (Structure-Activity Relationship) campaigns, especially in late-stage lead optimization where unpredictable impurities disrupt both purity profiles and interpretability of bioactivity. With our process, stray byproducts sit well below 0.5%, so users spend less time purifying and more time investigating real biological effects.

    Material scientists also send reports of using the compound in the construction of charge-transport layers for advanced polymers and OLED research. Here, control over trace metals and microheterogeneity matters for film formation and device performance. Purity doesn’t just look good on a COA; it translates directly into the reproducibility and robustness of finished devices. Our internal records show complaint rates falling markedly since we implemented an extra step for phosphonium salt recrystallization, prompted by direct feedback from a client synthesizing surface coatings.

    Lessons from the Ground: Handling and Use

    Safety data matters there in texts, but much of the real world boils down to good habits. Operators in our plant wear full PPE not out of bureaucracy but because the methylated quinoline group can occasionally form skin-sensitive residues. Our storage rooms log temperature and humidity minute by minute, so we have a clear picture when a researcher calls in about a batch that “turned” after shipping. Those are lessons learned not from spec sheets but from working alongside skilled operators for years.

    We teach internal teams and customers the value of small aliquots—drawing single-use quantities avoids the bane of cross-contamination, which, in high-throughput settings, becomes a real risk. A customer developing a kinase inhibitor shared that a speck of the wrong compound jeopardized weeks of effort. By packaging in small, rigorously sealed vials, we help users avoid expensive reruns.

    Glass, not plastic, serves as our vessel of choice for final product containment because it doesn’t leach or interact with phosphonium salts over time. It’s a lesson learned after initial batches displayed slight off-coloration when stored in lined HDPE—a cost of experience, not a theoretical warning.

    Process Improvements Driven by Customer Science

    We believe manufacturing should respond to what scientists encounter at their workbenches, not just what analysts expect from a catalogue item. One customer, working on heterocyclic ligand design, reported unwanted oxidative changes after repeated handling. Our chemists returned to the pipeline, questioning everything from the powder’s grind size to the transfer tubing. By altering the fill process to impose a blanket of inert gas, shelf life improved without a bump in cost.

    Another partner in the pharma sector needed isotopically enriched phenyl groups. We traced the obstacle to an upstream fluorination method that speckled impurities in the product. Instead of claiming “typical” values, we adopted the specific, higher-grade precursor and mapped impurity clearance, so downstream isotope incorporation carried no unwanted signatures.

    And it isn’t just about adoption. Analytics drive confidence, so we deployed updated qNMR and UHPLC-MS (ultra-high performance liquid chromatography–mass spectrometry) techniques to secure proof for every delivered lot. Each improvement circles back: more reliable reactions, less batch-to-batch troubleshooting, and trust built into our daily work.

    Distinct from the Marketplace: Real Manufacturer, Real Control

    Purveyors who buy and relabel bulk intermediates often blur the line between source and origin. For us, there’s no “middleman mystery.” All steps happen in-house, from cyclopropanation and aromatic coupling to careful control of phosphonium counterions. If there are odd findings in a vial, we trace them to a date, a shift, a technician’s log—not a faceless batch code from a distant bulk supplier.

    The difference in outcomes is hard to miss on the research side. Direct manufacturing control means we can iterate faster—tweaking reagent ratios, playing with temperature ramps, and listening to the feedback loop coming from actual users of the product. Sometimes the best insight comes not from the literature but from researchers who lose a key reaction to some unexpected variable. We solve those problems upstream.

    Commitment to Transparency and Traceability

    Traceability helps everyone. Every bottle carries its journey, from raw material audit to final COA with one-click access to prior batch data. For projects under intensifying regulatory scrutiny, transparency like this smooths approvals and builds trust. A recent compliance review praised this approach—not for excess paperwork, but for practical readiness in uncovering and responding swiftly to irregularities, should they arise.

    Our experience points to the value of a hands-on approach. We’re not only chemists making materials but partners at the technical bench—anticipating the issues that matter, learning from each batch, and holding ourselves to a practical rigour that’s more than lip service. For every milligram that leaves our gates, a real story of adaptation, feedback, and tangible result sits behind it.

    Looking Forward: Evolving with New Chemical Demands

    Shifts in chemical research priorities push manufacturing to change, and we welcome that. Each year we field more requests for enantiomerically pure materials, more rigorous impurity maps, and tailored batch sizes. We respond by reinvesting not only in polished reactors or more sensitive detectors, but also in continuous skills training and feedback loops with the scientists who depend on our work.

    Today, [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido stands as a direct response to the needs we hear from discovery teams: reliable, consistent, and straightforward to handle, with integrity earned batch by batch on the production floor. It’s more than a reagent—it’s a reflection of the honest discussions, tough lessons, and minor miracles that come from making advanced chemicals day in and day out.